Transplanted multipotent human fetal neural stem cells (hfNSCs) significantly improved the
function of parkinsonian monkeys in a prior study primarily by neuroprotection, with only 3 …

Embryonic stem cells (ESCs)-based therapies have been increasingly recognized as a
potential tool to replace or support cells and their function damaged by the …

Parkinson's disease (PD) is characterized by the progressive loss of midbrain dopaminergic
neurons (DaNs) of the substantia nigra pars compacta and the decrease of dopamine in the …

The transplantation of fetal mesencephalic cell suspensions into the brain striatal system is
an emerging treatment for Parkinson's disease. However, one objection to this procedure is …

The use of human embryonic stem cells (hESCs) to repair diseased or injured brain is
promising technology with significant humanitarian, societal and economic impact …

Neural stem cells (NSCs) have been proposed as tools for treating neurodegeneration
because of their capacity to give rise to cell types appropriate to the structure in which they …

The present study was designed to analyse whether continuous overexpression of glial cell
line‐derived neurotrophic factor (GDNF) in the striatum by a recombinant lentiviral vector …

Embryonic stem cells (ESCs) represent a promising source of midbrain dopaminergic (DA)
neurons for applications in Parkinson disease. However, ESC-based transplantation …

Embryonic stem cell-based therapies exhibit great potential for the treatment of Parkinson's
disease (PD) because they can significantly rescue PD-like behaviors. However, whether …

Parkinson's disease (PD) is a neurodegenerative disease characterized by progressive
degeneration of nigrostriatal dopaminergic (DA) neurons. The therapeutic potential of glial …